COVID-19: Vaccine immunogenicity, interleukin-6 inhibitors, mucormycosis

COVID-19: Vaccine immunogenicity, interleukin-6 inhibitors, mucormycosis

BMJ talk medicine

Kieran Walsh, clinical director at BMJ, asks editors from BMJ Learning and BMJ Best Practice to summarise the latest clinical guidance related to Covid-19.

Abigail Davis, GP and section editor, covers the latest evidenc…

Related tracks

See all